This research study investigates the issue of finite-time passivity analysis of neutral-type neural networks with mixed time-varying delays. The time-varying delays are distributed, discrete and neutral in that the upper bounds for the delays are available. We are investigating the creation of sufficient conditions for finite boundness, finite-time stability and finite-time passivity, which has never been performed before. First, we create a new Lyapunov–Krasovskii functional, Peng–Park’s integral inequality, descriptor model transformation and zero equation use, and then we use Wirtinger’s integral inequality technique. New finite-time stability necessary conditions are constructed in terms of linear matrix inequalities in order to guarantee finite-time stability for the system. Finally, numerical examples are presented to demonstrate the result’s effectiveness. Moreover, our proposed criteria are less conservative than prior studies in terms of larger time-delay bounds.
The issue of the robust exponential passivity analysis for uncertain neutral-type neural networks with mixed interval time-varying delays is discussed in this work. For our purpose, the lower bounds of the delays are allowed to be either positive or zero adopting the combination of the model transformation, various inequalities, the reciprocally convex combination, and suitable Lyapunov–Krasovskii functional. A new robust exponential passivity criterion is received and formulated in the form of linear matrix inequalities (LMIs). Moreover, a new exponential passivity criterion is also examined for systems without uncertainty. Four numerical examples indicate our potential results exceed the previous results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.